Finance

Beta
Lists
DOCS:NYSE
Doximity Inc
$20.02
-3.89%
(-0.81) 1D
Jun 25, 2:42:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DOCS...
Open
$20.61
High
$20.75
Low
$19.87
Mkt. cap
3.66B
Avg. vol.
4.95M
Volume
1.45M
P/E ratio
20.33
52-wk high
$76.51
52-wk low
$17.15
EPS
$0.98
Beta
1.30
Shares outstanding
131.98M
No. of employees
880
Open
$20.61
High
$20.75
Low
$19.87
Mkt. cap
3.66B
Avg. vol.
4.95M
Volume
1.45M
P/E ratio
20.33
52-wk high
$76.51
52-wk low
$17.15
EPS
$0.98
Beta
1.30
Shares outstanding
131.98M
No. of employees
880
News stories
From sources across the web
Profile
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration. The company is based in San Francisco. Wikipedia
About Doximity Inc
CEOJeff Tangney
Employees880
FoundedJun 2010
HeadquartersSan Francisco, California, United States
SectorHealth care
Websitedoximity.com
Analyst ratings
Based on 20 analysts giving stock ratings to DOCS in the past 3 months
Buy
Buy
8
Hold
12
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for DOCS in the last 3 months.
Highest
Current $20.02
$42.00 (+109.79%)
Average
$25.88 (+29.27%)
Lowest
$18.00 (-10.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Buy
Maintained
$28.00
+39.9%
06/24/2026
Alexei Gogolev
J.P. Morgan
Hold
Reiterated
$26.00
+29.9%
06/25/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
$18.00
-10.1%
06/10/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
06/11/2026
Allen Lutz
Bank of America Securities
Buy
Maintained
$38.00
+89.8%
06/05/2026
Jailendra Singh
Truist Financial
Hold
Maintained
$19.00
-5.1%
05/18/2026
Glen Santangelo
Barclays
Hold
Downgraded
$20.00
-0.1%
05/14/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$30.00
+49.9%
05/14/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$42.00
+109.8%
05/14/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
$26.00
+29.9%
05/14/2026
Anne Samuel
J.P. Morgan
Hold
Maintained
$28.00
+39.9%
05/14/2026
Sean Dodge
BMO Capital
Hold
Maintained
$20.00
-0.1%
05/14/2026
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
$35.00
+74.8%
05/14/2026
David Roman
Goldman Sachs
Hold
Reiterated
$24.00
+19.9%
05/15/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
$25.00
+24.9%
05/15/2026
David Larsen
BTIG
Hold
Downgraded
-
-
05/14/2026
Vikram Kesavabhotla
Robert W. Baird
Hold
Downgraded
$18.00
-10.1%
05/14/2026
Brian Tanquilut
Jefferies
Hold
Downgraded
$19.00
-5.1%
05/14/2026
Ryan MacDonald
Needham
Buy
Reiterated
$27.00
+34.9%
05/14/2026
Scott Schoenhaus
KeyBanc
Hold
Maintained
-
-
05/14/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$25.00
+24.9%
04/27/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Initiated
$31.00
+54.8%
03/17/2026
Last report
May 13, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
$0.26 / $0.28
-7.93%miss
Revenue / Est. (USD)
145.37M / 143.91M
+1.02%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
145.91M
168.52M
185.05M
145.37M
Cost of goods sold
15.79M
16.42M
18.70M
19.41M
Cost of revenue
15.79M
16.42M
18.70M
19.41M
Research and development expenses
26.80M
30.20M
34.60M
39.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.64M
56.94M
59.78M
55.48M
Operating expense
75.44M
87.14M
94.38M
94.59M
Total operating expenses
91.23M
103.56M
113.08M
114.00M
Operating income
54.68M
64.96M
71.98M
31.37M
Other non operating income
-235.00K
-178.00K
-158.00K
-235.00K
EBT including unusual items
64.15M
72.94M
80.80M
32.12M
EBT excluding unusual items
64.32M
74.22M
80.76M
38.60M
Income tax expense
10.83M
10.88M
19.24M
13.01M
Effective tax rate
16.88%
14.92%
23.81%
40.49%
Other operating expenses
-
-
-
-
Net income
53.32M
62.06M
61.56M
19.11M
Net profit margin
36.54%
36.82%
33.27%
13.15%
Earnings per share
0.36
0.45
0.46
0.26
Interest and investment income
9.86M
9.44M
8.94M
7.46M
Interest expense
-
-
-
-
Net interest expenses
9.86M
9.44M
8.94M
7.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
55.78M
66.73M
74.06M
33.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of DOCS
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer